FASN and cervical carcinoma: In particular, FASN expression in CESC showed a significant increase in both stage and grade, and Shang et al. demonstrated that targeting FASN by the combination of miR-532-5p and the FASN inhibitor orlistat significantly inhibited lymph node metastasis in cervical cancer mouse xenografts [21].